InsidersTradesSigma
한미사이언스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 한미사이언스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 한미사이언스 has logged 14 insider filings. Market capitalisation: €2,915.1bn. The latest transaction was filed on 7 August 2026 (Sale). Among the most active insiders: 송영숙. Every trade is openly available.
14
Insider Decl.
n/a
Thresholds
€322m
4 ops.
Buy Volume
€82m
2 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,186 of 28,169 companies
49.9
score / 100
Value41
Quality59
FCF yld0.9%
Earn yld3.9%
EV/EBITDA21.2x
ROE15%
Gross mgn23%
Net mgn8.7%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 August 2026
Declarations14 total
14 of 14 declarations
About 한미사이언스
Hanmi Science is a South Korean company focused on the healthcare and pharmaceutical sector. It is listed on the XKRX market.